Altirkistani Bsaim A, Ashqar Alaa A, Bahathiq Dena M, Bougis Suaad M, Aljabri Ammar M, Hanafi Sawsan
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Department of Emergency Medicine, King Abdulaziz Medical City, Jeddah, SAU.
Cureus. 2023 Mar 16;15(3):e36250. doi: 10.7759/cureus.36250. eCollection 2023 Mar.
Opioids are the mainstay of treatment for acute pain in the emergency department. However, its misuse led to the investigation of alternative effective analgesic options for acute pain complaints such as ketamine. Therefore, this systematic review and meta-analysis aimed to determine the effectiveness of ketamine in comparison to opioids in the management of acute pain. This was a systematic review and meta-analysis of randomized controlled trials comparing ketamine to opioids for the relief of acute pain in the ED. Eligible studies were identified by searching the following electronic databases: Medline, Embase, and Central. Studies utilizing either the visual analog scale (VAS) or the numeric rating scale (NRS) for pain scoring in ketamine vs opioids were included. The revised Cochrane risk-of-bias tool for randomized trials was utilized. A random-effects model was performed, and all outcomes were pooled by the inverse variance weighting method. The total number of studies that met the criteria of systematic reviews was nine of which seven of them were included in the meta-analysis with 789 participants. The overall effect of NRS trials was the standardized mean difference (SMD) = -0.07, 95% confidence interval (CI) -0.31 to 0.17, P-value = 0.56, I =85%. While VAS trials showed an overall effect of SMD = -0.02, 95% CI -0.22 to 0.18, P = 0.84, I= 59%). Moreover, higher adverse events were reported in opioids; however, this was not statistically significant (SMD = 1.23, 95% CI 0.93-1.64, P = 0.15, I2 =38%). Ketamine for immediate pain relief at 15 minutes could be an effective alternative to opioids, but its overall effect in comparison to opioids for improving the pain has not shown a statistically significant difference. There was high heterogeneity in the included studies; thus, a sub-group analysis was performed.
阿片类药物是急诊科急性疼痛治疗的主要手段。然而,其滥用促使人们对诸如氯胺酮等急性疼痛主诉的替代有效镇痛选择进行研究。因此,本系统评价和荟萃分析旨在确定氯胺酮与阿片类药物相比在急性疼痛管理中的有效性。这是一项对随机对照试验进行的系统评价和荟萃分析,比较氯胺酮与阿片类药物在急诊科缓解急性疼痛的效果。通过检索以下电子数据库确定符合条件的研究:医学文献数据库(Medline)、荷兰医学文摘数据库(Embase)和循证医学图书馆(Central)。纳入了在氯胺酮与阿片类药物对比中使用视觉模拟量表(VAS)或数字评分量表(NRS)进行疼痛评分的研究。采用了修订后的Cochrane随机试验偏倚风险工具。进行随机效应模型分析,并通过逆方差加权法汇总所有结果。符合系统评价标准的研究总数为9项,其中7项纳入荟萃分析,共789名参与者。数字评分量表(NRS)试验的总体效应为标准化均数差(SMD)=-0.07,95%置信区间(CI)为-0.31至0.17,P值=0.56,I²=85%。而视觉模拟量表(VAS)试验显示总体效应为SMD=-0.02,95%CI为-0.22至0.18,P=0.84,I²=59%)。此外,阿片类药物报告的不良事件更多;然而,这在统计学上并不显著(SMD=1.23,95%CI为0.93 - 1.64,P=0.1